Global Complement Deficiency Tests Market Size, Status and Forecast 2021-2027

Complement is the group of serum glycoprotein, the part of innate immune system that enhances the ability of antibodies and macrophages to clear the damaged cells and pathogens. Complement also promotes inflammation and aids in enhancing the immune response. The complement system is activated through a cascade. Complement deficiency is a primary immunodeficiency disorder. Deficiency in any component of complement can lead to immunosuppression, infections and sepsis. Clinical indication for complement deficiency include bacterial infection, autoimmune disease or episodes of angioedema. The deficiency can be either inherited or acquired, also it can be either complete or partial. One can screen the complement deficiency using different diagnosis test such as by performing the total serum complement classic hemolytic complement test or alternative hemolytic complement test.
Rise in prevalence of chronic diseases such as kidney disease, serum sickness may be one of the factor resulting in rise of the global complement deficiency test market. Rise in the rate of common variable immunodeficiency disease, rise in recurrent microbial infection such as Streptococcus pneumoniae, Neisseria meningitides, and Neisseria gonorrhea are the key factors likely to propel the growth of the global complement deficiency test market through 2024. High cost of therapies and lack of proper reimbursement are the few of the factors that are likely to hamper the growth of the global complement deficiency market during the forecast period.

Market Analysis and Insights: Global Complement Deficiency Tests Market
The global Complement Deficiency Tests market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Complement Deficiency Tests market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Complement Deficiency Tests market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Complement Deficiency Tests market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Complement Deficiency Tests market.

Global Complement Deficiency Tests Scope and Market Size
Complement Deficiency Tests market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Complement Deficiency Tests market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Serological And Immunological Assay
Molecular Diagnostic Tests
Immunohistochemistry Techniques
Others

Segment by Application
Hospitals
Diagnostic Laboratories
Research Laboratories

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Wako Diagnostics
Kypha
Beckman Coulter
Thermo Fisher Scientific
Abbiotec
Acris Antibodies
Linscott's
Assaypro